| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $31,995,055 ) |
| 2024 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 19 | 11/8/2023 | NON-COMPETING CONTINUATION | $13,303,754 |
| 2024 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 009 | 19 | 8/16/2024 | SUPPLEMENT FOR EXPANSION | $3,287,548 |
| 2024 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 008 | 19 | 7/12/2024 | NON-COMPETING CONTINUATION | $0 |
| 2024 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 007 | 19 | 3/20/2024 | NON-COMPETING CONTINUATION | $15,403,753 |
| 2024 | 2023 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 006 | 18 | 12/11/2023 | SUPPLEMENT FOR EXPANSION | $0 |
| 2024 | 2023 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 005 | 18 | 12/11/2023 | SUPPLEMENT FOR EXPANSION | $0 |
| 2024 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 003 | 17 | 12/11/2023 | SUPPLEMENT FOR EXPANSION | $0 |
| 2024 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 001 | 17 | 12/4/2023 | SUPPLEMENT FOR EXPANSION | $0 |
| 2024 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 004 | 17 | 12/11/2023 | SUPPLEMENT FOR EXPANSION | $0 |
| 2024 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 002 | 17 | 12/11/2023 | SUPPLEMENT FOR EXPANSION | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $9,679,931 ) |
| 2023 | 2023 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 015 | 18 | 4/28/2023 | SUPPLEMENT FOR EXPANSION | $1,748,110 |
| 2023 | 2023 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 017 | 18 | 5/1/2023 | SUPPLEMENT FOR EXPANSION | $3,200,000 |
| 2023 | 2023 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 024 | 18 | 7/3/2023 | NON-COMPETING CONTINUATION | $5,000,000 |
| 2023 | 2023 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 014 | 18 | 3/29/2023 | NON-COMPETING CONTINUATION | $17,346,444 |
| 2023 | 2023 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 18 | 11/21/2022 | NON-COMPETING CONTINUATION | $16,063,039 |
| 2023 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 002 | 17 | 1/10/2023 | SUPPLEMENT FOR EXPANSION | $0 |
| 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 026 | 16 | 7/20/2023 | SUPPLEMENT FOR EXPANSION | -$500,081 |
| 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 027 | 16 | 7/20/2023 | SUPPLEMENT FOR EXPANSION | -$49,588 |
| 2023 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 012 | 17 | 3/24/2023 | SUPPLEMENT FOR EXPANSION | -$4,500,000 |
| 2023 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 016 | 17 | 5/1/2023 | SUPPLEMENT FOR EXPANSION | $0 |
| 2023 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 003 | 17 | 1/10/2023 | SUPPLEMENT FOR EXPANSION | $0 |
| 2023 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 001 | 17 | 1/9/2023 | SUPPLEMENT FOR EXPANSION | $0 |
| 2023 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 010 | 17 | 3/23/2023 | SUPPLEMENT FOR EXPANSION | -$1,500,000 |
| 2023 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 005 | 17 | 1/10/2023 | SUPPLEMENT FOR EXPANSION | $0 |
| 2023 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 009 | 17 | 3/23/2023 | SUPPLEMENT FOR EXPANSION | -$150,000 |
| 2023 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 013 | 17 | 3/24/2023 | SUPPLEMENT FOR EXPANSION | -$300,000 |
| 2023 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 011 | 17 | 3/24/2023 | SUPPLEMENT FOR EXPANSION | -$300,000 |
| 2023 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 008 | 17 | 1/11/2023 | SUPPLEMENT FOR EXPANSION | $0 |
| 2023 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 007 | 17 | 1/11/2023 | SUPPLEMENT FOR EXPANSION | $0 |
| 2023 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 006 | 17 | 1/10/2023 | SUPPLEMENT FOR EXPANSION | $0 |
| 2023 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 004 | 17 | 1/10/2023 | SUPPLEMENT FOR EXPANSION | $0 |
| 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 025 | 15 | 7/20/2023 | SUPPLEMENT FOR EXPANSION | -$4,166,810 |
| 2023 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 023 | 14 | 6/21/2023 | SUPPLEMENT FOR EXPANSION | -$5,560,116 |
| 2023 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 022 | 14 | 6/21/2023 | SUPPLEMENT FOR EXPANSION | -$16,651,068 |
|
| Issue Date FY: 2022 ( Subtotal = $78,343,151 ) (Continued on the next page) |
| 2022 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 011 | 17 | 6/1/2022 | SUPPLEMENT FOR EXPANSION | $8,044,100 |
| 2022 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 016 | 17 | 6/7/2022 | SUPPLEMENT FOR EXPANSION | $2,031,957 |
| 2022 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 012 | 17 | 6/2/2022 | SUPPLEMENT FOR EXPANSION | $11,222,643 |
| 2022 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 025 | 17 | 8/9/2022 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $5,571,540 |
| 2022 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 007 | 16 | 3/30/2022 | SUPPLEMENT FOR EXPANSION | $1,856,516 |
| 2022 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 015 | 17 | 6/6/2022 | SUPPLEMENT FOR EXPANSION | $4,105,979 |
| 2022 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 018 | 17 | 6/9/2022 | SUPPLEMENT FOR EXPANSION | $929,677 |
| 2022 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 008 | 16 | 5/23/2022 | SUPPLEMENT FOR EXPANSION | -$1,856,516 |
| 2022 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 026 | 17 | 8/23/2022 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $9,691,804 |
| 2022 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 009 | 17 | 5/27/2022 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $21,176,541 |
| 2022 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 014 | 17 | 6/3/2022 | SUPPLEMENT FOR EXPANSION | $4,937,125 |
| 2022 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 006 | 16 | 3/29/2022 | SUPPLEMENT FOR EXPANSION | $586,880 |
| 2022 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 005 | 16 | 3/18/2022 | SUPPLEMENT FOR EXPANSION | $1,324,786 |
|